Features of the Treatment of Sepsis in Complicated Diabetes Mellitus
Keywords:
sepsis, diabetes mellitus, complicated diabetes, hyperglycemia, insulin resistanceAbstract
Sepsis in patients with complicated diabetes mellitus presents a significant clinical challenge due to the interplay between the immune dysregulation caused by sepsis and the metabolic disturbances inherent in diabetes. This article explores the unique features of sepsis treatment in patients with diabetes, focusing on the pathophysiological mechanisms, diagnostic criteria, and therapeutic approaches. The dysregulated immune response in diabetes, which impairs both the recognition and clearance of pathogens, complicates the management of sepsis. Additionally, the metabolic imbalances such as hyperglycemia, insulin resistance, and diabetic ketoacidosis (DKA) exacerbate the septic state. This review evaluates current therapeutic strategies, including the use of broad-spectrum antibiotics, insulin therapy, fluid resuscitation, and adjunctive treatments such as corticosteroids and immunomodulatory agents. A particular emphasis is placed on the need for personalized treatment plans that take into account the severity of both diabetes and sepsis. Early identification, aggressive management, and continuous monitoring are critical for improving patient outcomes.
References
Singer, M., Deutschman, C. S., Seymour, C. W., et al. (2016). The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Journal of the American Medical Association, 315(8), 801-810. doi:10.1001/jama.2016.0287
Van den Berghe, G., Wouters, P., Weekers, F., et al. (2001). Intensive insulin therapy in critically ill patients. The New England Journal of Medicine, 345(19), 1359-1367. doi:10.1056/NEJMoa011300
Dellinger, R. P., Levy, M. M., Rhodes, A., et al. (2013). Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Critical Care Medicine, 41(2), 580-637. doi:10.1097/CCM.0b013e31827e83af
Pittet, D., Rangel-Frausto, S., Li, N., et al. (1999). Systemic inflammatory response syndrome, sepsis, severe sepsis, and septic shock: Incidence, morbidities, and outcomes in surgical ICU patients. Intensive Care Medicine, 25(3), 175-185. doi:10.1007/s001340050839
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., et al. (2002). Hyperglycemia: An independent marker of in-hospital mortality in patients with undiagnosed diabetes. Journal of Clinical Endocrinology and Metabolism, 87(3), 978-982. doi:10.1210/jcem.87.3.8341
Evans, T., Carpenter, A., Keely, S., et al. (2020). Management of hyperglycemia in septic patients: Current perspectives. Journal of Critical Care, 58, 56-62. doi:10.1016/j.jcrc.2020.04.007
Marik, P. E., Khangoora, V., Rivera, R., et al. (2017). Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study. Chest, 151(6), 1229-1238. doi:10.1016/j.chest.2016.11.036
Cawcutt, K. A., & Peters, S. G. (2014). Severe sepsis and septic shock: Clinical overview and update on management. Mayo Clinic Proceedings, 89(11), 1572-1578. doi:10.1016/j.mayocp.2014.07.009
Finfer, S., Chittock, D. R., Su, S. Y., et al. (2009). Intensive versus conventional glucose control in critically ill patients. The New England Journal of Medicine, 360(13), 1283-1297. doi:10.1056/NEJMoa0810625
Rhodes, A., Evans, L. E., Alhazzani, W., et al. (2017). Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Medicine, 43(3), 304-377. doi:10.1007/s00134-017-4683-6
Deane, A. M., Horowitz, M., & Barret, M. P. (2014). Glycemic variability and outcomes in critically ill patients with sepsis. Critical Care Medicine, 42(12), 2583-2591. doi:10.1097/CCM.0000000000000618
Stegenga, M. E., Vincent, J. L., Vail, G. M., et al. (2010). Diabetes does not alter mortality or hemostatic and inflammatory responses in patients with severe sepsis. Critical Care Medicine, 38(2), 539-545. doi:10.1097/CCM.0b013e3181bc80b2
Levy, M. M., Fink, M. P., Marshall, J. C., et al. (2003). 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Medicine, 29(4), 530-538. doi:10.1007/s00134-003-1662-x
Kumar, A., Roberts, D., Wood, K. E., et al. (2006). Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Critical Care Medicine, 34(6), 1589-1596. doi:10.1097/01.CCM.0000217961.75225.E9
Krinsley, J. S., & Preiser, J. C. (2015). Glycemic control, diabetes status, and mortality in sepsis patients. Critical Care, 19(1), 137. doi:10.1186/s13054-015-0868-7
Gazkhanovna, M. A., Makhmatovich, A. K., & Utkirovich, D. U. (2022). Clinical efficacy of extracorporeal and intravascular hemocorrection methods in psoriasis. ACADEMICIA: An International Multidisciplinary Research Journal, 12(2), 313-318.
Ruziboeva, O. N., Abdiev, K. M., Madasheva, A. G., & Mamatkulova, F. K. (2021). Modern Methods Of Treatment Of Hemostasis Disorders In Patients With Rheumatoid Arthritis. Ученый XXI века, 8.
Madasheva, A. G., Yusupova, D. M., & Abdullaeva, A. A. EARLY DIAGNOSIS OF HEMOPHILIA A IN A FAMILY POLYCLINIC AND THE ORGANIZATION OF MEDICAL CARE. УЧЕНЫЙ XXI ВЕКА, 37.
